newsfilter
← Latest News
GlobeNewswire·

SELLAS to Present at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting

NEW YORK, April 23, 2025 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ:SLS) ("SELLAS" or the "Company"), a late-stage clinical biopharmaceutical company focused on the development of novel therapies for